Unique solution of remote monitoring and
predictive medicine for your COPD patients

COPD exacerbations are detected approximately 4.4¹ days before they occur thanks to our solution

COPD, a major public health issue

Chronic Obstructive Pulmonary Disease (COPD) is a condition that describes the progressive deterioration of the respiratory system due to obstruction of the airways.

Discover our solution

millions

of COPD patients in Europe²

%

of patients hospitalized after a first exacerbation are readmitted within 30 days³

billions of €

This is what COPD costs in Europe, of which 29 billion euros are attributable to exacerbations⁴

With millions of patients affected And a major impact on hospitalizations and health costs, the management of COPD is a major issue.

Bora care®, towards preventive management of COPD exacerbations

Our clinically validated, predictive medical remote monitoring solution enables continuous remote monitoring of your patients with chronic respiratory failure.

By detecting the risk of exacerbation early using our BVS³ score, our solution contributes to preventive and personalized care for a better quality of life for patients.

1. Patient monitored remotely at home

2. Calculation of the BVS³ predictive score

3. Optimized support

Benefits for all stakeholders in the care pathway

Reduce hospitalizations and costs

Helps reduce hospitalizations, thereby reducing healthcare costs thanks to our BVS³ predictive score.

Early intervention

Allows intervention before symptoms worsen by adapting treatment at the right time using data reported on the Bora connect® platform.

Streamlining the care pathway

Optimizes the organization of care, by facilitating team coordination and improving the patient care pathway through therapeutic monitoring on the Bora connect® platform.

Request a demo

An international scientific council of excellence

Our international scientific committee plays a key role in the development of our solution.

Their expertise guarantees an approach based on best medical practices and helps to develop our solution to ensure its relevance and effectiveness for healthcare professionals, and to adapt the care of patients with COPD by integrating Bora care® into care pathways.

Gerard Criner

MD President Temple University School of Medicine, Philadelphia, Pennsylvania, USA

Alvar Agusti

MD Respiratory Institute, Hospital Clinic, IDIBAPS, Univ. Barcelona Spain

Professor Nicolas Roche

Pulmonologist Head of the Pulmonology Department, Cochin Hospital (APHP)

Mars Miravitlles

MD Vice-president of the European Respiratory Society (ERS) 2024-2025

A certified and recognized solution

Medical device of
class IIa

Clinically validated

Certified compliant with the ANS standard

GDPR compliant solution

Our health data is hosted in HDS environments to ensure security standards. Our goal? To guarantee patients and caregivers an optimized, compliant, and secure solution.

Biosency at the service of health

6 patent families

14 international scientific publications

8 clinical trials measure clinical benefits

+500k days of remote monitoring

Learn more

Contact us

You are a professional and you would like to know more about our
Bora care® solution?

¹Result of the E-Meuse study, presented at the European Respiratory Society (ERS) 2024 congress
²The economic and health burden of COPD in Western Europe: forecasting through 2050, Elroy Boers, Angier Allen, Meredith Barrett, 2023
³ Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis, JS Alqahtani, CM Njoku, B. Bereznicki, et al., 2020
⁴Global Burden of Chronic Obstructive Pulmonary Disease Through 2050, Elroy Boers, PhD1; Meredith Barrett, PhD2; Jason G. Su, PhD3; et al, 2023

Unique solution of remote monitoring andpredictive medicine for your COPD patients